Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
Clinical trial NCT02469298 · COMPLETED
Trial details
- NCT number
- NCT02469298
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2016-04-25
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.